Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation.

@article{Moreno2012CosteffectivenessOT,
  title={Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation.},
  author={Santiago Gonz{\'a}lez Moreno and Nicola Novielli and Nicola J. Cooper},
  journal={The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation},
  year={2012},
  volume={31 5},
  pages={450-8}
}
BACKGROUND Left ventricular assist devices (LVADs) are being proposed as a life-saving therapeutic alternative to conventional medical management for people with end-stage heart failure awaiting transplantation. However, cost-effectiveness assessments of first-generation LVADs have not been encouraging. The cost-effectiveness of the enhanced second-generation LVAD HeartMate II (Thoratec, Pleasanton, CA) is estimated here. METHODS A probabilistic Markov model was developed to extrapolate… CONTINUE READING

From This Paper

Topics from this paper.
27 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

Similar Papers

Loading similar papers…